Breaking Medical Cannabis News

Retail hemp THC beverages are expanding while federal regulators classify HHC as illegal. Here’s what Florida medical marijuana patients should understand.

Target has added hemp THC beverages to stores in Florida and other states. Here’s what medical marijuana patients should understand about these products.

Federal regulators say HHC does not qualify as legal hemp. Here’s what Florida medical marijuana patients should understand about synthetic cannabinoids and cannabis policy.

A major legal shift just unfolded in Texas — and it highlights how quickly hemp-derived THC products can be impacted by court decisions. In a rare split outcome: The Texas Supreme Court effectively shut down the delta-8 THC market A Travis County district court allowed other hemp businesses to continue operating — at least temporarily For patients across the country, including Florida, this moment reinforces an important distinction: A major legal shift just unfolded in Texas

Marijuana has been reclassified under federal law. Learn what this shift means for medical marijuana patients, providers, and the cannabis industry.

April 20 highlights the importance of physician-guided medical marijuana programs in Florida. Learn how the evaluation process works and what patients should know about qualifying conditions.

Federal policy discussions continue around marijuana rescheduling timelines. Here is what Florida medical marijuana patients should understand right now.

Learn what happens during a Florida medical marijuana evaluation, how physicians assess qualifying conditions, and how patients can prepare for certification under physician supervision.

Federal policymakers are evaluating tighter rules for hemp-derived THC products. Here’s what Florida medical marijuana patients should understand about potential changes.

A new federal policy update addresses marijuana rescheduling and possible hemp-derived THC restrictions. Here’s what the developments mean for Florida medical marijuana patients today.

The Florida Supreme Court has declined to review a lawsuit tied to a cannabis legalization ballot initiative. While the decision affects future legalization efforts, Florida’s medical marijuana program remains unchanged for patients.

2026 Cannabis State of the Industry: Navigating Schedule III rescheduling, 280E tax reform, and the 0.4mg THC "Hemp Cliff" with OMNI and Sage Monroe.

The DOJ has asked the Supreme Court to uphold the federal gun ban for marijuana users, even if rescheduling moves forward. Here’s what Florida medical marijuana patients should know.

A legal dispute over roughly 71,000 petition signatures could determine whether voters will see a recreational cannabis amendment on the November 2026 ballot — or whether reform efforts will once again stall.

A recent large-scale study is generating attention for suggesting that lifetime cannabis use in middle-aged and older adults may be associated with slightly larger brain volumes and modestly better cognitive performance.

In a recent legislative vote, Florida lawmakers approved a measure that would reduce the cost of medical marijuana identification cards for qualifying veterans, acknowledging both the unique healthcare needs of former service members and the financial barriers many face.

Organizers of the recreational marijuana ballot initiative have confirmed they are short of the required number of valid signatures needed to move the measure forward. Despite months of collecting petitions across the state, the campaign did not reach the legal threshold required for ballot qualification.

ATF Signals Possible Shift on Marijuana and Gun Rights — What Medical Cannabis Patients Need to Know

Senate Bill 1056 — filed in the Florida Senate in January 2026 — would create a new statute in Florida law prohibiting the possession of open containers of edibles, hemp products, low-THC cannabis, marijuana, THC beverages, and similar products in motor vehicles.

In late 2025, the U.S. Senate approved President Trump’s nominee to lead the Office of National Drug Control Policy (ONDCP) — commonly known as the “drug czar.” What makes this confirmation notable is not just the role itself, but the nominee’s public support for medical marijuana, arriving at the same moment federal marijuana rescheduling is actively underway.